Global health problems can be solved by finding common ground between the needs of patients in poor countries and the pragmatic needs of companies
BIO Ventures for Global Health (BVGH) is a non-profit organization whose mission is to save lives by accelerating the development of novel biotechnology-based drugs, vaccines, and diagnostics to address the unmet medical needs of the developing world. BVGH has a unique perspective – we are able to look at the health problems facing poor countries through a dual lens of expertise in both global health and the biopharmaceutical industry.
BVGH spurs biopharmaceutical company involvement in global health by:
- Increasing biopharmaceutical and global health innovator partnerships
- Designing and advocating for market-based incentives for research and development
- Synthesizing and disseminating critical information and quantitative analyses
BIO Ventures for Global Health History
BIO Ventures for Global Health was founded in 2004 with a start-up grant from the Bill & Melinda Gates Foundation, and the support of the Biotechnology Industry Association (BIO) and the Rockefeller Foundation. BVGH currently receives funding from the Bill & Melinda Gates Foundation and the Pharmaceutical Research and Manufacturers of America (PhRMA), as well as other companies and individuals.